@article{lewderivry:hal-04283874,
TITLE = {Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group},
AUTHOR = {Lew-Derivry, Lucille and Marceau-Renaut, Alice and Fenwarth, Laur{\`e}ne and Cuccuini, Wendy and Ballerini, Paola and Ferreboeuf, Maxime and Guilmatre, Audrey and Petit, Arnaud and Gandemer, Virginie and Rialland, Fanny and Schneider, Pascale and Robert, Bruno G{\'e}rard, Michel, B.G.M. and Bertrand, Yves and Baruchel, Andr{\'e} and Preudhomme, Claude and Leverger, Guy and Lapillonne, Helene},
URL = {https://hal.science/hal-04283874},
JOURNAL = {Leukemia},
PUBLISHER = {Springer Nature},
VOLUME = {37},
NUMBER = {8},
PAGES = {1723-1726},
YEAR = {2023},
MONTH = Aug, DOI = {10.1038/s41375-023-01931-y},
KEYWORDS = {Child ; Core Binding Factor Alpha 2 Subunit ; Humans ; Leukemia, Myeloid, Acute ; Mutation ; Prognosis ; transcription factor RUNX1 ; RUNX1 protein, human ; acute myeloid leukemia ; adolescent ; Article ; cancer mortality ; cancer prognosis ; child ; controlled study ; cytogenetics ; cytology ; event free survival ; female ; frameshift mutation ; France ; gene deletion ; gene frequency ; gene mutation ; human ; leukemia remission ; major clinical study ; male ; missense mutation ; nonsense mutation ; overall survival ; pediatric patient ; risk assessment ; risk factor ; RUNX1 gene ; genetics ; mutation ; prognosis},
PDF = {https://hal.science/hal-04283874/file/s41375-023-01931-y.pdf},
HAL_ID = {hal-04283874},
HAL_VERSION = {v1},
}